These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 5753024)

  • 1. [Systemic erythematosus--the blood].
    Yamaguchi H
    Nihon Rinsho; 1968 Dec; 26(12):3426-9. PubMed ID: 5753024
    [No Abstract]   [Full Text] [Related]  

  • 2. [Changes of the indicators of hemostasis during corticosteroid treatment of systemic lupus erythematosus].
    Iakumova NIa; Ivanova AV; Sukhanov AA
    Vopr Revm; 1975; (1):63-5. PubMed ID: 1121805
    [No Abstract]   [Full Text] [Related]  

  • 3. [Blood tyrosine and the corticosteroid treatment of systemic lupus erythematosus].
    Rass IT; Borisov IA; Nikishova TA; Sura VV
    Ter Arkh; 1977; 49(8):110-5. PubMed ID: 929380
    [No Abstract]   [Full Text] [Related]  

  • 4. [Circulating anticoagulants in systemic lupus erythematosus].
    Durán-Suárez JR
    Med Clin (Barc); 1983 Jul; 81(5):203-6. PubMed ID: 6621162
    [No Abstract]   [Full Text] [Related]  

  • 5. [Change in the amino acid spectrum of the blood serum in patients with lupus erythematosus under the effect of therapy].
    Pavlova LT
    Vestn Dermatol Venerol; 1970 Jul; 44(7):11-4. PubMed ID: 5511088
    [No Abstract]   [Full Text] [Related]  

  • 6. [Hematologic abnormalities in generalized lupus erythematosus].
    Romero García F; Armando Aguilar J; Gray Santacruz C; Delgado Lamas JL; Vázquez Villegas V; Rodríguez Carrillo J; Perla Navarro AV; Galván Villegas F
    Rev Invest Clin; 1988; 40(2):119-24. PubMed ID: 3175364
    [No Abstract]   [Full Text] [Related]  

  • 7. The coagulation abnormalities in systemic lupus erythematosus.
    Gonyea L; Herdman R; Bridges RA
    Thromb Diath Haemorrh; 1968 Dec; 20(3):457-64. PubMed ID: 4179647
    [No Abstract]   [Full Text] [Related]  

  • 8. Haemostatic abnormalities in systemic lupus erythematosus.
    Gladman DD; Urowitz MB; Tozman EC; Glynn MF
    Q J Med; 1983; 52(207):424-33. PubMed ID: 6647751
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Modification of systemic lupus erythematosus in connection with steroid hormone therapy (clinico-morphological parallels)].
    Vinogradova OM; Potekseva MA
    Sov Med; 1966 Aug; 29(8):25-33. PubMed ID: 5991389
    [No Abstract]   [Full Text] [Related]  

  • 10. Chronic lupus erythematosus: observations on long-term survivors of "suppressive" therapy of lupus nephritis with prednisolone.
    Mackay IR
    Perspect Nephrol Hypertens; 1973; 1 Pt 2(0):1211-7. PubMed ID: 4139686
    [No Abstract]   [Full Text] [Related]  

  • 11. [Use of the preparation essentiale in the therapy of lupus erythematosus].
    Glavinskaia TA; Novikov AI; Pavlova LT
    Vestn Dermatol Venerol; 1983 May; (5):4-7. PubMed ID: 6880388
    [No Abstract]   [Full Text] [Related]  

  • 12. [Anti-factor XI circulating anticoagulant (author's transl)].
    Durán Suárez JR; Vilaseca J; Ordeig J; Triginer J
    Sangre (Barc); 1981; 26(5-A):631-7. PubMed ID: 7323919
    [No Abstract]   [Full Text] [Related]  

  • 13. [Presocyl in the treatment of lupus erythematosus].
    Glavinskaia TA; Zernov VP; Ostroumova TN
    Vestn Dermatol Venerol; 1976 Jul; (7):51-3. PubMed ID: 997883
    [No Abstract]   [Full Text] [Related]  

  • 14. [The evaluation of hemostatic disorders in patients with systemic lupus erythematosus].
    Arshinov AV; Lapin VA; Raĭt IuA
    Ter Arkh; 1999; 71(5):38-40. PubMed ID: 10399229
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intraplatelet and urinary serotonin concentrations in systemic lupus erythematosus with reference to its clinical manifestations.
    Kanai H; Tsuchida A; Yano S; Naruse T
    J Med; 1989; 20(5-6):371-90. PubMed ID: 2534129
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A circulating anticoagulant directed against factor XIa in systemic lupus erythematosus.
    DiSabatino CA; Clyne LP; Malawista SE
    Arthritis Rheum; 1979 Oct; 22(10):1135-8. PubMed ID: 486223
    [No Abstract]   [Full Text] [Related]  

  • 17. Effect of peripheral blood lymphocytes from systemic lupus erythematosus patients on human bone marrow granulocyte precursor cells (colony-forming units in culture).
    Sugimoto M; Wakabayashi Y; Shiokawa Y; Takaku F
    Stem Cells (1981); 1982; 2(3):164-76. PubMed ID: 7163917
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Objective evaluation of remote results of treatment of systemic lupus erythematosus].
    Ivanova MM; Nasonova VA; Folomeeva OM; Speranskiĭ AI; Kozlova VN
    Ter Arkh; 1977; 49(9):60-6. PubMed ID: 929421
    [No Abstract]   [Full Text] [Related]  

  • 19. [Uric acid of plasma in patients with rheumatic heart disease, rheumatoid arthritis and systemic lupus erythematosus and its dynamics during treatment].
    Belov VA
    Ter Arkh; 1976; 48(5):96-9. PubMed ID: 948806
    [No Abstract]   [Full Text] [Related]  

  • 20. [The use of dibazol in the complex therapy of lupus erythematosus].
    Glavinskaia TA
    Vestn Dermatol Venerol; 1966 Jul; 40(7):33-6. PubMed ID: 6001633
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.